MedTrace Logo

SLP Model Development in the Diagnosis of COPD Patients

NCT04584801 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 201

Last updated 2024-09-19

No results posted yet for this study

Summary

This is an observational, comparative, multicentre study to develop a model for the Thora3Di™ against standard practice in patients who are undergoing investigation for COPD. The core methodology involves capturing of data during a short period of measurement of breathing using SLP against spirometric outcomes.

Conditions

  • COPD
  • Healthy Smoker

Interventions

DEVICE

Structured Light Plethysmography

Development Phase (Original Part A): Participants will have two 5-minute SLP measurements (Pre and Post bronchodilator). Participants will also undergo standard of care spirometry assessment

Sponsors & Collaborators

  • Pneumacare Ltd

    lead INDUSTRY

Principal Investigators

  • Mona Bafadhel, PhD · King's College London

  • Dennis Wat, MD · Liverpool Heart and Chest Hospital NHS Trust

  • Brendan Cooper, PhD · University Hospital Birmingham NHS Foundation Trust

  • Paul Walker, MD · Liverpool University Hospital NHS Foundation Trust

  • Richa Singh, MD · London Barts Health NHS Foundation Trust

  • Mitra Shahidi, MD · Buckinghamshire Healthcare NHS Trust

  • Sanjay Ramakrishnan, MD · Oxford University Hospitals NHS Trust

  • Suraj Rajput, MSc · Medway Community Healthcare

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-05
Primary Completion
2023-06-15
Completion
2023-06-15

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04584801 on ClinicalTrials.gov